![]() |
|
|
Vol. 303, Issue 1, 403-411, October 2002
1-Adrenergic Receptor-Induced
Contraction and Extracellular Signal-Regulated Kinase Activation in the
Bovine Inferior Alveolar Artery
Department of Pharmacology, Creighton University School of
Medicine, Omaha, Nebraska
The endogenous adrenergic agonists norepinephrine (NE) and
epinephrine regulate vascular tone by stimulating
1-adrenergic receptors (ARs) on smooth muscle cells to
cause contraction. In addition,
1-ARs also couple to
growth factor pathways, through stimulation of mitogen-activated
protein kinases (MAPKs). MAPKs are a family of serine-threonine kinases
that include extracellular signal-regulated kinase (ERK) and a variety
of other kinases that are able to activate transcription factors when
stimulated. We examined
1-AR stimulation of contraction
and ERK activation in the bovine inferior alveolar artery (BIAA), using
in vitro contraction studies and Western blotting. Using antagonists
selective for individual adrenergic receptor types, we found that only
1-ARs were coupled to ERK activation and contraction. NE
stimulated contraction (EC50 = 11 µM) and ERK
activation (EC50 = 21 µM) with similar potency.
Using
1-AR subtype-selective antagonists, we identified
the
1-AR subtypes coupled to each response. Affinity values for
1-AR subtype-selective antagonists were
consistent with
1A-AR-mediated contraction. In contrast,
simultaneous treatment with concentrations of these antagonists
selective for each
1-AR subtype (
1A-,
1B-, and
1D-AR) was required to inhibit
ERK activation, suggesting that all three
1-ARs activate
ERK in BIAA. Transmural electrical stimulation of BIAA segments
resulted in activation of ERK, which was inhibited by the
1-AR-selective antagonist BE 2254 (2-[[
-(4-hydroxyphenyl)ethyl]aminomethyl]-1-tetralone). These data suggest that in an intact artery, NE released from sympathetic nerves stimulates
1-ARs to cause contraction
and ERK activation, and that redundancy among subtypes exists for
1-AR activation of ERK.
This article has been cited by other articles:
![]() |
S. M. Summers, Y. Hayashi, S. V. Nguyen, T. M. Nguyen, and R. E. Purdy Hindlimb unweighting induces changes in the p38MAPK contractile pathway of the rat abdominal aorta J Appl Physiol, July 1, 2009; 107(1): 121 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Erami, H. Zhang, A. Tanoue, G. Tsujimoto, S. A. Thomas, and J. E. Faber Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H744 - H753. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, D. Chalothorn, L. F. Jackson, D. C. Lee, and J. E. Faber Transactivation of Epidermal Growth Factor Receptor Mediates Catecholamine-Induced Growth of Vascular Smooth Muscle Circ. Res., November 12, 2004; 95(10): 989 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and J. E. Faber Gene deletion of dopamine {beta}-hydroxylase and {alpha}1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2106 - H2114. [Abstract] [Full Text] [PDF] |
||||